Skip to NavigationSkip to content

News

Leading diabetes specialist Dr Sue Roberts has been appointed as the new National Clinical Director for Diabetes, and will oversee the development of...
Roche has recorded a $2.8 billion net loss for 2002 after writing off CHF9 billion costs following its embarrassing exit from the vitamins market and...
Medicines regulator the EMEA has asked the European Union for a subsidy increase of nearly 13% to pay for its expansion, including the induction of...
A multi-million pound bidding war for Oxford GlycoSciences has broken out between UK biotech rivals Celltech and Cambridge Antibody Technology.
Bayer has refuted allegations that it concealed serious side-effects of its statin Lipobay before it was withdrawn in July 2001.
SkyePharma long-term profitability was brought a step closer after it finally secured licensing deals for two of its lead products.
Pfizer is to build a new $35 million clinical research centre in an R&D otspotin New Haven, Connecticut.
Abbott Laboratories says US approval of its rheumatoid arthritis product Humira has come earlier than expected, and will now increase spending on its...
UK clinical trials technology company ClinPhone is to develop its European business to serve clusters of pharmaceutical and biotech companies on the...
Roche has in-licensed the first medicine from Chugai since the companies merged their Japanese operations in October last year.
Mission Statement
Pharmafile.com is a leading portal for the pharmaceutical industry, providing industry professionals with pharma news, pharma events, pharma service company listings and pharma jobs,
Site content is produced by our editorial team exclusively for Pharmafile.com and our industry newspaper Pharmafocus. Service company profiles and listings are taken from our pharmaceutical industry directory, Pharmafile, and presented in a unique Find and Compare format to ensure the most relevant matches